At the news
? NEUTRALIMPACT 3/10 424B5 filed Nov 9, 2026 at 16:10 ET
Zimmer Biomet is issuing $500M of 5.850% senior notes due 2036 in an underwritten debt offering, with net proceeds of ~$495.1M to be used for general corporate purposes including potential repayment of near-term maturities (€500M 2.425% notes due Dec 2026 and/or $600M 4.700% notes due Feb 2027), share repurchases, and acquisitions. The offering follows a Q3 earnings report that showed modest revenue growth and raised guidance, and is concurrent with a separate €500M euro note offering.
- $500,000,000 aggregate principal amount of 5.850% notes due 2036
- Net proceeds estimated at ~$495.1 million after underwriting discount and expenses
- Notes are unsecured, unsubordinated obligations ranking equally with existing unsecured debt
- Proceeds may be used to repay portions of €500M 2.425% notes due Dec 2026 and/or $600M 4.700% notes due Feb 2027
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access